Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yelin Song, Jie Yu, LingLing Li, Lei Wang, Liangle Dong, Guangmin Xi, Yun Jing Lu & Zuowei Li. (2022) Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer. Bioengineered 13:4, pages 10998-11011.
Read now
Read now
Busheng Xue, Jiansong Zhao, Penghui Feng, Jia Xing, Hongliang Wu & Yan Li. (2019) Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies. OncoTargets and Therapy 12, pages 549-559.
Read now
Read now
Yijie You, Rong Wang, Naiyuan Shao, Feng Zhi & Yilin Yang. (2019) Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma. OncoTargets and Therapy 12, pages 2383-2396.
Read now
Read now
Kellen Cristine Tjioe, Denise Tostes Oliveira & Julie Gavard. (2016) Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma. Nutrition and Cancer 68:5, pages 838-847.
Read now
Read now
Articles from other publishers (25)
Waseem Ashraf, Tanveer Ahmad, Nicolas Reynoird, Ali Hamiche, Yves Mély, Christian Bronner & Marc Mousli. (2023) Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1. Molecules 28:16, pages 5997.
Crossref
Crossref
Stefano Ciaco, Viola Mazzoleni, Aqib Javed, Sylvia Eiler, Marc Ruff, Marc Mousli, Mattia Mori & Yves Mély. (2023) Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells. Bioorganic Chemistry 137, pages 106616.
Crossref
Crossref
Yuchong Peng, Rong Tang, Liuyang Ding, Rirong Zheng, Youhong Liu, Linglong Yin, Yongming Fu, Tanggang Deng & Xiong Li. (2023) Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation. European Journal of Pharmacology 942, pages 175522.
Crossref
Crossref
Mahmoud Alhosin. (2023) Epigenetics Mechanisms of Honeybees: Secrets of Royal Jelly. Epigenetics Insights 16.
Crossref
Crossref
Tian-hao Guo, Yuan-yuan Li, Sheng-wei Hong, Qian-yu Cao, Heng Chen, Yuan Xu, Guo-liang Dai & Gang Shao. (2022) Evidence for Anticancer Effects of Chinese Medicine Monomers on Colorectal Cancer. Chinese Journal of Integrative Medicine 28:10, pages 939-952.
Crossref
Crossref
Marion Turpin & Gilles Salbert. (2022) 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Komal Anjum & Ye Xuewei. (2022) Epigenetic Strategies to Discover Novel Fungal Secondary Metabolites. Journal of Biomedical Research & Environmental Sciences 3:3, pages 246-263.
Crossref
Crossref
Abdelhakim Bouyahya, Hamza Mechchate, Loubna Oumeslakht, Ikrame Zeouk, Sara Aboulaghras, Abdelaali Balahbib, Gokhan Zengin, Mohammad Amjad Kamal, Monica Gallo, Domenico Montesano & Nasreddine El Omari. (2022) The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Biomolecules 12:3, pages 367.
Crossref
Crossref
Nishat Fatima, Syed Shabihe Raza Baqri, Atrayee Bhattacharya, Nii Koney-Kwaku Koney, Kazim Husain, Ata Abbas & Rais A. Ansari. (2021) Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy. Frontiers in Genetics 12.
Crossref
Crossref
Mahmoud Alhosin, Omeima Abdullah, Asaad Kayali & Ziad Omran. (2021) A Fast Ubiquitination of UHRF1 Oncogene Is a Unique Feature and a Common Mechanism of Thymoquinone in Cancer Cells. Applied Sciences 11:16, pages 7633.
Crossref
Crossref
Xiangjun Qi, Hongbin Xu, Peng Zhang, Guoming Chen, Zhiqiang Chen, Caishan Fang & Lizhu Lin. (2021) Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-18.
Crossref
Crossref
Man Zhang, Rui Wang, Jie Tian, Mengqiu Song, Ran Zhao, Kangdong Liu, Feng Zhu, Jung‐Hyun Shim, Zigang Dong & Mee‐Hyun Lee. (2021)
Targeting LIMK1 with luteolin inhibits the growth of lung cancer
in vitro
and
in vivo
. Journal of Cellular and Molecular Medicine 25:12, pages 5560-5571.
Crossref
Crossref
Omeima Abdullah, Ziad Omran, Salman Hosawi, Ali Hamiche, Christian Bronner & Mahmoud Alhosin. (2021) Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex. Genes 12:5, pages 622.
Crossref
Crossref
Chunsik Lee & Jong Kyong Kim. (2020) Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of Cellular Physiology 236:4, pages 2318-2332.
Crossref
Crossref
Chunming Gu, Zhao Yin, Hong Nie, Yanjun Liu, Juhua Yang, Guiping Huang, Jianping Shen, Liguo Chen & Jia Fei. (2020) Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1. BMC Biology 18:1.
Crossref
Crossref
Shizhao Li, Min Chen, Yuanyuan Li & Trygve O. Tollefsbol. (2019) Prenatal epigenetics diets play protective roles against environmental pollution. Clinical Epigenetics 11:1.
Crossref
Crossref
Sravani Polepalli, Sophia M George, R Valli Sri Vidya, Gabriel Sunil Rodrigues, L. Ramachandra, Raghu Chandrashekar, Deepak Nayak M, Praveen P.N. Rao, Richard G. Pestell & Mahadev Rao. (2019) Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. The International Journal of Biochemistry & Cell Biology 114, pages 105558.
Crossref
Crossref
Qian Zuo, Renyi Wu, Xi Xiao, Caizhi Yang, Yuqing Yang, Chao Wang, Lizhu Lin & Ah‐Ng Kong. (2018) The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. Journal of Cellular Biochemistry 119:11, pages 9573-9582.
Crossref
Crossref
Guillermo Senisterra, Hugh Y. Zhu, Xiao Luo, Hailong Zhang, Guoliang Xun, Chunliang Lu, Wen Xiao, Taraneh Hajian, Peter Loppnau, Irene Chau, Fengling Li, Abdellah Allali-Hassani, Peter Atadja, Counde Oyang, En Li, Peter J. Brown, Cheryl H. Arrowsmith, Kehao Zhao, Zhengtian Yu & Masoud Vedadi. (2018) Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor Domain. SLAS Discovery 23:9, pages 930-940.
Crossref
Crossref
Leonardo Elia, Paolo Kunderfranco, Pierluigi Carullo, Marco Vacchiano, Floriana Maria Farina, Ignacio Fernando Hall, Stefano Mantero, Cristina Panico, Roberto Papait, Gianluigi Condorelli & Manuela Quintavalle. (2018) UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease. Journal of Clinical Investigation 128:6, pages 2473-2486.
Crossref
Crossref
Anna Palko-Labuz, Kamila Sroda-Pomianek, Anna Uryga, Edyta Kostrzewa-Suslow & Krystyna Michalak. (2017) Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells. Biomedicine & Pharmacotherapy 88, pages 232-241.
Crossref
Crossref
Harsimran Sidhu & Neena Capalash. (2017) UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics. Tumor Biology 39:2, pages 101042831769220.
Crossref
Crossref
Mahmoud Alhosin, Ziad Omran, Mazin A. Zamzami, Abdulrahman L. Al-Malki, Hani Choudhry, Marc Mousli & Christian Bronner. (2016) Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Rajnee Kanwal, Manish Datt, Xiaoqi Liu & Sanjay Gupta. (2016) Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases. PLOS ONE 11:9, pages e0162956.
Crossref
Crossref
Natthawan Kittiratphatthana, Veerapol Kukongviriyapan, Auemduan Prawan & Laddawan Senggunprai. (2016) Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species. Journal of Pharmacy and Pharmacology 68:9, pages 1184-1192.
Crossref
Crossref